Jolt Health Inc.

JOLT

CA4798611063

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 08:21:35 14/06/2024 pm IST			5-day change	1st Jan Change
0.01 ^CAD	+100.00%		+100.00%	+100.00%

24/05	Jolt Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Jolt Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 24, 2024 at 07:39 pm IST

Jolt Health Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was CAD 0.21225 million compared to CAD 0.288152 million a year ago.

Latest news about Jolt Health Inc.

Jolt Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05	CI
Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Jolt Health Inc. announced that it has received CAD 0.5 million in funding	27/03	CI
Jolt Health Inc. Announces Board Changes	08/03	CI
Jolt Health Inc. announced that it expects to receive CAD 0.5 million in funding	08/03	CI
Jolt Health Inc. announced that it expects to receive CAD 0.38 million in funding	22/11	CI
Jolt Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11	CI
Jolt Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04	CI
Jolt Health Inc. announced that it has received CAD 0.099875 million in funding	19/23/19	CI
Jolt Health to Seek Acquisitions	16/23/16	CI
Jolt Health Inc. announced that it expects to receive CAD 0.4 million in funding	15/23/15	CI
Jolt Health Inc. Announces Gerald Tritt Joined the Company as A Director	02/23/02	CI
Jolt Health Inc. Announces Gerald Tritt Joins the Company as CEO	02/23/02	CI
Jolt Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Love Pharma Inc. will Change its Ticker to JOLT from LUV	22/23/22	CI
Love Pharma Inc. will Change its Name to Jolt Health Inc	22/23/22	CI
Love Pharma Inc. Auditor Raises 'Going Concern' Doubt	01/23/01	CI
Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
LOVE Pharma Inc. to Evaluate Mining Opportunities	06/23/06	CI
An unknown buyer acquired MicroDoz Therapy Inc from Love Pharma Inc. for CAD 0.1 million.	14/22/14	CI
Love Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/22/17	CI
Love Pharma Inc. Announces Board Changes	02/22/02	CI
Love Pharma Inc. completed the acquisition of Doc Hygiene Pharmaceuticals Inc.	19/22/19	CI
LOVE Pharma Provides an Update on the Launch of its Psilocybin Trials at John Hopkins University	18/22/18	CI
Love Pharma Co. Provides Update on the Advancement of the Previously Announced Trial Focused Upon Clinical Applications for Psilocybin Assisted Therapy for Addiction to Be Conducted at Johns Hopkins	13/22/13	CI

Chart Jolt Health Inc.

Duration

Period

More charts

Company Profile

Jolt Health Inc. is a Canada-based life sciences company focused on healthcare, biotechnology and artificial intelligence. The Company holds licenses for therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America. The Company's Wellness Product Portfolio is comprised of wellness products and the underlying intellectual property, concentrating on sexual health, with or without the benefit of CBD, acquired pursuant to various product licenses. In particular, the Company has rights to utilize a range of products and the related intellectual property pursuant to the product licenses, including CBD oral strips, Arouse RX gel with CBD and/or THC, CBD/THC biphasic mints/candies, Female Sexual Dysfunction supplement (FSD Supplement), ToConceive, and Male Enhancement Gel With CBD.

Sector

Pharmaceuticals

Calendar

12/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JOLT HEALTH INC.	+100.00%	9L
NOVO NORDISK A/S	+41.96%	63TCr
JOHNSON & JOHNSON	-7.15%	35TCr
MERCK & CO., INC.	+18.77%	33TCr
ABBVIE INC.	+8.79%	30TCr
ASTRAZENECA PLC	+18.02%	25TCr
ROCHE HOLDING AG	+1.27%	22TCr
NOVARTIS AG	+11.95%	22TCr
AMGEN INC.	+3.68%	16TCr
PFIZER, INC.	-4.38%	16TCr